ZA996622B - Treatment of BPH with cGMP elevators. - Google Patents

Treatment of BPH with cGMP elevators.

Info

Publication number: ZA996622B
Authority: ZA; South Africa
Prior art keywords: bph; treatment; cgmp elevators; cgmp; elevators
Prior art date: 1998-10-21

Application number

ZA9906622A

Other languages

English (en)

Inventor

Michael Grant Wyllie

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-21

Filing date

1999-10-20

Publication date

2001-04-20

1999-10-20 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-04-20 Publication of ZA996622B publication Critical patent/ZA996622B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA9906622A 1998-10-21 1999-10-20 Treatment of BPH with cGMP elevators. ZA996622B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10509798P	1998-10-21	1998-10-21

Publications (1)

Publication Number	Publication Date
ZA996622B true ZA996622B (en)	2001-04-20

Family

ID=22304008

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9906622A ZA996622B (en)	1998-10-21	1999-10-20	Treatment of BPH with cGMP elevators.

Country Status (11)

Country	Link
EP (1)	EP1020190A3 (xx)
JP (1)	JP2000128804A (xx)
KR (1)	KR20000029222A (xx)
AR (1)	AR020850A1 (xx)
AU (1)	AU5597799A (xx)
CA (1)	CA2287122A1 (xx)
CO (1)	CO5150210A1 (xx)
HU (1)	HUP9903732A3 (xx)
IL (1)	IL132406A0 (xx)
PE (1)	PE20001282A1 (xx)
ZA (1)	ZA996622B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW536402B (en)	1998-06-26	2003-06-11	Yamanouchi Pharma Co Ltd	Pharmaceutical composition for the therapy of voiding dysfunction
CA2383466C (en)	1999-09-16	2009-08-25	Tanabe Seiyaku Co., Ltd.	Aromatic nitrogen-containing 6-membered cyclic compounds
TWI265925B (en)	1999-10-11	2006-11-11	Pfizer	Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
AU2001241142B2 (en)	2000-04-28	2005-09-22	Tanabe Seiyaku Co., Ltd.	Cyclic compounds
US7273868B2 (en)	2000-04-28	2007-09-25	Tanabe Seiyaku Co., Ltd.	Pyrazine derivatives
IT1318674B1 (it) *	2000-08-08	2003-08-27	Nicox Sa	Faramaci per l'incontinenza.
JP2001288115A (ja) *	2001-02-07	2001-10-16	Yamanouchi Pharmaceut Co Ltd	下部尿路症治療剤
ATE447970T1 (de)	2001-02-08	2009-11-15	Ono Pharmaceutical Co	Mittel zur behandlung von harnwegserkrankungen, umfassend mittel zur kontrolle des lpa-rezeptors
CN1503797A (zh)	2001-02-26	2004-06-09	田边制药株式会社	吡啶并嘧啶或二氮杂萘衍生物
DE10135815A1 (de) *	2001-07-23	2003-02-06	Bayer Ag	Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
WO2007039075A2 (en) *	2005-09-29	2007-04-12	Bayer Healthcare Ag	Pde inhibitors and combinations thereof for the treatment of urological disorders
US20070093493A1 (en) *	2005-10-12	2007-04-26	Lilly Icos Llc	Treatment of benign prostatic hypertrophy and lower urinary tract symptoms
CA2634019A1 (en) *	2005-12-20	2007-06-28	Pfizer Products Inc.	Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist
JP2010540621A (ja) *	2007-10-02	2010-12-24	ドンアファーマシューティカルカンパニーリミテッド	良性前立腺肥大症および下部尿路症状の治療または予防用組成物、およびその治療または予防方法
KR20110062943A (ko) *	2009-12-04	2011-06-10	주식회사종근당	퀴나졸린 유도체를 유효성분으로 하는 전립선 비대증 예방 또는 치료제
CN108841802B (zh)	2012-05-11	2023-06-09	珍白斯凯尔有限公司	抗炎性肽及包含其的组合物
KR101873773B1 (ko)	2012-05-11	2018-08-02	주식회사 젬백스앤카엘	류마티즘 관절염 예방 또는 치료 조성물
JP6272853B2 (ja)	2012-07-11	2018-01-31	ジェムバックスアンドカエルカンパニー，リミティド	細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
WO2014171792A1 (ko)	2013-04-19	2014-10-23	주식회사 카엘젬백스	허혈성 손상 치료 및 예방용 조성물
EP4063863A1 (en)	2013-06-07	2022-09-28	Gemvax & Kael Co., Ltd.	Gv1001, gemcitabine and capecitabine for use in the treatment of pancreatic cancer in high eotaxin baseline level patients
CN105324123B (zh)	2013-06-21	2022-02-08	珍白斯凯尔有限公司	激素分泌调节剂、包含该调节剂的组合物、和利用其控制激素分泌的方法
CN110755599A (zh)	2013-10-23	2020-02-07	珍白斯凯尔有限公司	用于治疗和预防良性前列腺增生的组合物
EP3072519B1 (en)	2013-11-22	2020-08-19	Gemvax & Kael Co., Ltd.	Peptide having angiogenesis inhibitory activity and composition containing same
US11058744B2 (en)	2013-12-17	2021-07-13	Gemvax & Kael Co., Ltd.	Composition for treating prostate cancer
ES2908096T3 (es)	2014-04-11	2022-04-27	Gemvax & Kael Co Ltd	Péptido con actividad inhibidora de la fibrosis y composición que lo contiene
WO2015167067A1 (ko)	2014-04-30	2015-11-05	주식회사 카엘젬백스	장기, 조직 또는 세포 이식용 조성물, 키트 및 이식 방법
KR102413243B1 (ko)	2014-12-23	2022-06-27	주식회사 젬백스앤카엘	안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
CN107405380B (zh)	2015-02-27	2021-04-20	珍白斯凯尔有限公司	用于预防听觉损伤的肽及其包含该肽的组合物
JP6923453B2 (ja)	2015-07-02	2021-08-18	ジェムバックスアンドカエルカンパニー，リミティド	抗ウイルス活性効能を有するペプチド及びこれを含む組成物
WO2017176087A1 (ko)	2016-04-07	2017-10-12	주식회사 젬백스앤카엘	텔로머라제 활성 증가 및 텔로미어 연장 효능을 가지는 펩티드 및 이를 포함하는 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9114760D0 (en) *	1991-07-09	1991-08-28	Pfizer Ltd	Therapeutic agents
GB9401090D0 (en) *	1994-01-21	1994-03-16	Glaxo Lab Sa	Chemical compounds
DE19540642A1 (de) *	1995-11-01	1997-05-07	Stief Christian Georg Priv Doz	Verwendung von Inhibitoren der Phosphodiesterase bei der Behandlung von Prostataerkrankungen
DE19642322A1 (de) *	1996-10-14	1998-04-16	Bayer Ag	Neue 3-Heterocyclyl-substituierte Pyrazolderivate
DE19709126A1 (de) *	1997-03-06	1998-09-10	Bayer Ag	Arylamin-, -oxy-, -thio-substituierte Dihydropurinone und Pyrazolopyrimidine
CA2295616C (en) *	1997-07-09	2009-05-12	Christian Georg Stief	Use of phosphodiesterase inhibitors in the treatment of prostatic diseases

1999
- 1999-10-14 IL IL13240699A patent/IL132406A0/xx unknown
- 1999-10-15 EP EP99308148A patent/EP1020190A3/en not_active Withdrawn
- 1999-10-19 PE PE1999001053A patent/PE20001282A1/es not_active Application Discontinuation
- 1999-10-19 CA CA002287122A patent/CA2287122A1/en not_active Abandoned
- 1999-10-20 HU HU9903732A patent/HUP9903732A3/hu unknown
- 1999-10-20 AU AU55977/99A patent/AU5597799A/en not_active Abandoned
- 1999-10-20 AR ARP990105301A patent/AR020850A1/es not_active Application Discontinuation
- 1999-10-20 ZA ZA9906622A patent/ZA996622B/xx unknown
- 1999-10-20 JP JP11297837A patent/JP2000128804A/ja active Pending
- 1999-10-21 CO CO99066723A patent/CO5150210A1/es unknown
- 1999-10-21 KR KR1019990045737A patent/KR20000029222A/ko not_active Ceased

Also Published As

Publication number	Publication date
CO5150210A1 (es)	2002-04-29
KR20000029222A (ko)	2000-05-25
AU5597799A (en)	2000-05-04
IL132406A0 (en)	2001-03-19
EP1020190A2 (en)	2000-07-19
JP2000128804A (ja)	2000-05-09
HU9903732D0 (en)	1999-12-28
HUP9903732A2 (hu)	2000-08-28
AR020850A1 (es)	2002-05-29
HUP9903732A3 (en)	2002-01-28
CA2287122A1 (en)	2000-04-21
EP1020190A3 (en)	2000-10-25
PE20001282A1 (es)	2000-11-18

Publication	Publication Date	Title
ZA996622B (en)	2001-04-20	Treatment of BPH with cGMP elevators.
ZA981842B (en)	1999-09-13	Treated horticultural substrates.
ZA200000411B (en)	2000-09-06	Machine-room-less elevator.
ZA200007642B (en)	2001-12-19	Treatment of airborne microorganisms.
ZA978918B (en)	1998-04-07	Metal surface treatment.
ZA200202822B (en)	2003-09-23	Oncolytic combinations for the treatment of cancer.
ZA97986B (en)	1997-08-18	Treatment of liquors.
HUP0104543A3 (en)	2003-08-28	Lime treatment
ZA978640B (en)	1998-03-27	Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
ZA973843B (en)	1997-11-10	Treatment of asthma with TNFR-lg.
GB9815312D0 (en)	1998-09-16	Biomas treatment
SG68707A1 (en)	1999-11-16	Tank treatment assembly
ZA991144B (en)	1999-08-12	Treatment of iron chloride.
GB9800954D0 (en)	1998-03-11	Well treatment with micro-organisms
ZA200203166B (en)	2003-06-25	Treatment of cancer.
ZA99253B (en)	2000-07-14	Treatment of waxes.
AU2002256967A1 (en)	2002-09-12	Treating or reducing the risk of cardiovascular disease
ZA200007396B (en)	2002-02-27	Method of treatment.
PL368994A1 (en)	2005-04-04	Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
GB9715222D0 (en)	1997-09-24	Bath lift
AP2004002980A0 (en)	2004-03-31	The treatment of lipodystrophy.
GB9820844D0 (en)	1998-11-18	Bath lifts
GB9815497D0 (en)	1998-09-16	Treatment
GB9818524D0 (en)	1998-10-21	Inorgasmia treatment
ZA994585B (en)	2001-01-15	Treatment of water.